Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-40.9%
operating margin TTM
-33.29%
revenue TTM
418.22 Million
revenue per share TTM
1.65$
valuation ratios | |
|---|---|
| pe ratio | -5.77 |
| peg ratio | 0.00 |
| price to book ratio | -4.65 |
| price to sales ratio | 2.24 |
| enterprise value multiple | -6.13 |
| price fair value | -4.65 |
profitability ratios | |
|---|---|
| gross profit margin | 23.52% |
| operating profit margin | -33.29% |
| pretax profit margin | -40.53% |
| net profit margin | -40.9% |
| return on assets | -68.96% |
| return on equity | 101.55% |
| return on capital employed | -89.73% |
liquidity ratios | |
|---|---|
| current ratio | 2.32 |
| quick ratio | 2.29 |
| cash ratio | 0.74 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 3.07 |
| operating cycle | 46.05 |
| days of payables outstanding | 5.81 |
| cash conversion cycle | 40.24 |
| receivables turnover | 8.49 |
| payables turnover | 62.78 |
| inventory turnover | 118.79 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.73 |
| debt equity ratio | -0.90 |
| long term debt to capitalization | -6.71 |
| total debt to capitalization | -9.22 |
| interest coverage | -4.16 |
| cash flow to debt ratio | 0.88 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.40 |
| cash per share | 1.39 |
| operating cash flow per share | 1.41 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.88 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 130.48 |
Frequently Asked Questions
When was the last time BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported earnings?
BioCryst Pharmaceuticals, Inc. (BCRX) published its most recent earnings results on 05-08-2026.
What is BioCryst Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)'s trailing twelve months ROE is 101.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioCryst Pharmaceuticals, Inc. (BCRX) currently has a ROA of -68.96%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BCRX's net profit margin stand at?
BCRX reported a profit margin of -40.9% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BCRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.32 in the most recent quarter. The quick ratio stood at 2.29, with a Debt/Eq ratio of -0.90.